Grünenthal is an independent, research-based, pharmaceutical company with international operations. It has been under family-ownership since its foundation in 1946. Grünenthal's products are marketed in more than 80 countries, and the number of subsidiaries is growing constantly. In the meantime Grünenthal employs round about 5,000 people world-wide, who have made a great contribution to the company's success.
Grünenthal products
The treatment of serious medical conditions with pharmaceutical products is one of the pillars of modern medical practice. It is the goal of Grünenthal to help the medical profession improve treatment by providing drugs that satisfy unmet medical needs.
Bolar Pharmaceuticals Ltd markets TRAMAL® and it is available as Capsules, Injectables and Drops. Please visit www.grunenthal.com for more information on Tramal.
ETHICON, a global medical device company, has been a leader in surgical sutures (stitches) for more than 100 years. Today, we have expanded our expertise into wound management, women's health, and cardiovascular surgery. We have four business units that operate separately under the ETHICON umbrella, yet share the synergy of being not only part of ETHICON, but of Johnson & Johnson, the world's most comprehensive and broadly based manufacturer of healthcare products.
ETHICON enjoys a reputation for developing quality products to enhance the lives of patients and for providing outstanding service to customers. Headquartered in Somerville, New Jersey, ETHICON presently conducts business in 52 countries and employs approximately 11,000 employees in its various worldwide locations.
ETHICON Products is the worldwide leader in suture products and suture technology, and is one of the most recognizable and well-respected brand names in the hospital environment. The division has a long history of innovation in providing products - including sutures, topical adhesives, surgical meshes and wound drains - that enhance patient care.
Companies around the world use Pall Corporation's products and expertise to solve complex contamination problems
Pall Corporation serves the diverse needs of the medical industry by drawing upon our expertise and resources to provide critical contamination control. Specifically engineered for the filtration of blood and its components, respiration, parenteral therapy and cardiovascular and general surgical applications, our filtration products are a critical element for infection control and blood safety.
We are sensitive to the intense pressures for cost-containment and to the increased focus on preventative care. As a result, our emphasis is on not only improving patient outcomes, but also reducing the overall cost of providing that care. We are dedicated to improving the process of all health care applications where filters are required and to creating solutions for our customers.
Because the products discussed may have different labeling in different countries, please click here for a comprehensive Medical Devices Update.
Bolar Pharmaceuticals Ltd. © 2005. Designed by Tishri Nig Ent.
